Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
Crinetics Pharmaceuticals Research and Development Expense (Annual) : 328.17M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 328.17M |
| December 31, 2024 | 237.37M |
| December 31, 2023 | 167.43M |
| December 31, 2022 | 129.24M |
| December 31, 2021 | 83.33M |
| Date | Value |
|---|---|
| December 31, 2020 | 56.05M |
| December 31, 2019 | 41.51M |
| December 31, 2018 | 24.48M |
| December 31, 2017 | 9.233M |
| December 31, 2016 | 5.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.754B |
| Johnson & Johnson | 14.83B |
| Eli Lilly & Co. | 13.34B |
| Bristol Myers Squibb Co. | 9.492B |
| Corcept Therapeutics, Inc. | 254.91M |